| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.27B | +35.9% | +91.4% |
| R&D Expense | $96.0M | +104.7% | +105.9% |
| SG&A Expense | $387.0M | +61.2% | +121.3% |
| Operating Income | -$47.0M | -117.4% | -131.0% |
| Interest Expense | $48.0M | +236.0% | +236.4% |
| Pre-tax Income | -$88.0M | -133.3% | -161.6% |
| Income Tax | -$16.0M | -141.1% | -174.4% |
| Net Income | -$72.0M | -132.0% | -159.3% |
| EPS (Basic) | -$0.87 | -123.0% | -142.6% |
| EPS (Diluted) | -$0.87 | -123.1% | -142.9% |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $462.0M | -21.4% | +20.7% |
| Accounts Receivable | $1.75B | +111.5% | +145.8% |
| Inventory | $1.50B | +161.4% | +192.5% |
| Current Assets | $4.06B | +89.2% | +133.6% |
| Total Assets | $24.53B | +383.2% | +434.3% |
| Current Liabilities | $2.27B |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | -101.2% |
| Investing Cash Flow | $95.0M | — | +461.9% |
| Financing Cash Flow | -$213.0M | — | -22.9% |
| +136.5% |
| Long-term Debt | $4.86B | +244.3% | +257.8% |
| Total Liabilities | $9.24B | +267.3% | +251.4% |
| Stockholders' Equity | $15.29B | +497.1% | +679.3% |